NCT06704139View on ClinicalTrials.gov

Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions

Cesarean Section

Interventions

DRUG

Morphine - .25 mg

Fifty patients will receive intrathecal morphine

DRUG

fentanyl + morphine

Fifty patients will receive intrathecal morphine and fentanyl

DRUG

Ondansetron + Dexamethasone

All patients will receive a compination of intravenous 4mg ondansteron and 8mg dexamethasone 15 minutes before spinal anathesia

All Listed Sponsors

lead

Assiut University

OTHER

NCT06704139 - Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section | Biotech Hunter | Biotech Hunter